Sign inJoin waitlistJoin the waitlist

John Schallenkamp

Assoc Professor Clinical Pract · University of Colorado School of Medicine

Credentials: · · · · ·

History

University of Colorado School of Medicine
Present

Mayo Clinic
2005–2008
Mayo Clinic
2001–2005
Preliminary or Transitional Year
2000–2001
Medical College of Wisconsin
1996–2000

Research

Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging
International journal of radiation oncology · 2005 · First of 4 authors · 196 citations
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617…
JAMA Oncology · 2016 · 146 citations
Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates
International journal of radiation oncology · 2007 · First of 5 authors · 129 citations

Jeff Bradley
2 papers
Yolanda Garces
2 papers
Adam Walter
1 paper
AJ
Alcee Jumonville
1 paper
AP
Andrew Poklepovic
1 paper
Andrew Salner
1 paper
Anne Tsao
1 paper
Arnab Chakravarti
1 paper
AK
Atul Kumar
1 paper
Benjamin Movsas
1 paper
BF
Bryan Faller
1 paper
Carl Gay
1 paper

Grants

Montana Cancer Consortium NCORP
National Cancer Institute · UG1
Contact PI · $11M · Montana Cancer Consortium
2014–2027

Clinical trials

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2027–2032
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2027
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2029
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2026–2030